Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai IDF Pharmaceutical is a specialized pharmaceutical company focused on the development and manufacturing of complex drug delivery systems, particularly inhalation and transdermal formulations. The company leverages its proprietary dry powder inhaler (DPI) technology and transdermal patch platforms to develop high-quality generic and innovative drugs for respiratory and central nervous system disorders. Shanghai IDF provides comprehensive services ranging from formulation R&D to large-scale GMP manufacturing. Their portfolio includes treatments for asthma, COPD, and Parkinson's disease, aiming to provide affordable and effective alternatives to global blockbuster medications. The company is recognized for its expertise in particle engineering and device design, which are critical for the efficacy of inhaled therapies. With a strong focus on the Chinese market and international standards, Shanghai IDF continues to expand its pipeline of complex generics and value-added medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海爱的发.